Drug Profile
NS 1546
Latest Information Update: 22 Jan 1997
Price :
$50
*
At a glance
- Originator NeuroSearch
- Developer GlaxoSmithKline; NeuroSearch
- Class Antidepressants; Nootropics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders; Major depressive disorder
Most Recent Events
- 22 Jan 1997 Discontinued-Preclinical for Cognition disorders (Unknown route)
- 06 Jan 1997 Discontinued-Preclinical for Depression in Denmark (Unknown route)
- 06 Jan 1997 Discontinued-Preclinical for Depression in United Kingdom (Unknown route)